Clarification: Child Seat Recall story
More than 500,000 child car seats made by a company called Diono are being recalled because they may not adequately protect children in a crash.
This startup grows real human skin for burn victims
A Salt Lake City-based startup has figured out a way to grow real human skin for burn victims in less than 24 to 48 hours, instead of using traditional skin grafts that could take weeks.
Lilly tops Street 3Q forecasts, considers business sale
Eli Lilly and Co. (LLY) on Tuesday reported third-quarter earnings of $555.6 million.
Eli Lilly says profit falls, to mull sale of animal health business
Eli Lilly and Co, one of the world's top insulin makers, on Tuesday reported a 28.5 percent drop in quarterly profit and said it was reviewing options, including a sale or an IPO, for its Elanco Animal Health business.
Swiss drugs maker Novartis reports 7 percent rise in 3Q net
Swiss pharmaceuticals company Novartis is reporting net income rose 7 percent in the third quarter behind growth for its psoriasis treatment Cosentyx, its eye care business and several cancer drugs.
Mitsubishi recalls 161,167 vehicles in US, Canada
Mitsubishi Motors Corp. is recalling 161,167 vehicles in the U.S. and Canada because electric relays can cause the engine to stall or overheat.
Kia recalls Souls in US for second time
Kia Motors Corp. is recalling 342,381 vehicles in the U.S. for a second time because the first repair may not have solved a steering defect.
California company recalls vegetables over listeria fears
A California company has voluntarily recalled packaged vegetables distributed throughout the U.S. and Canada because of possible bacterial contamination.
Dr. Oz says medical marijuana could be key in ending opioid crisis
Every day, more than 90 Americans die after overdosing on opioids, according to the National Institute of Health.
US judge to review Trump health care payments cut
A U.S. judge is set to hear arguments on Monday about whether to block President Donald Trump's decision to terminate controversial payments to health insurance companies under Obamacare.
Recalls this week: wind-up toys, ottomans, wood chippers
More than a half-million windup toys are being recalled this week because a piece poses a choking hazard to young children.
Dr. Oz says losing weight is the most 'patriotic' thing you can do
As Congress and President Donald Trump continue to battle it out in Washington over health care reform, talk show host and cardiothoracic surgeon, Dr. Mehmet Oz, says the fight should be directed at reducing Americans’ waistlines.
Daimler profits hit by costs of diesel emissions recall
German automaker Daimler says net profit fell 16 percent in the third quarter as a voluntary recall to improve diesel emissions hurt earnings at its Mercedes-Benz luxury car brand.
Trump's ObamaCare subsidy shutdown could lead to free insurance
If President Donald Trump prevails in shutting down a major "Obamacare" health insurance subsidy, it would have the unintended consequence of making free basic coverage available to more people, and making upper-tier plans more affordable.
FDA approves cancer breakthrough that costs $375,000 per treatment
The U.S. Food and Drug Administration on Wednesday approved Yescarta, a new gene therapy to treat patients with certain types of lymphoma, marking the second approval for this potential breakthrough approach to fighting cancer.
Medicaid costs, enrollments steady after post-ObamaCare surge: Report
Despite ongoing uncertainty regarding the future of Medicaid, enrollment and costs stabilized during fiscal year 2017, according to a new survey.
Surprise! 4 things you didn't know were taxable
Tax season begins in just a few months, which means there's precious little time left to prevent unwelcome tax surprises next April.
Medicare open enrollment: 3 things to consider
How do you choose Parts A (hospitalization), B (medical insurance) and D (prescription drugs)? Should you go with Medicare Advantage (Part C)? Here is what you need to know.
Swiss biotech group Roche sees 5 pct rise in 9-month sales
Swiss biotech company Roche says sales grew 5 percent in the first nine months of the year, crediting new product launches and citing double-digit growth in the pharmaceuticals division in the U.S. market.
FDA approves Gilead cancer gene therapy; price set at $373,000
U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.












